XWELL (NASDAQ:XWEL) Posts Earnings Results, Beats Estimates By $0.34 EPS

XWELL (NASDAQ:XWEL) released its quarterly earnings results on Friday. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.60) by $0.34, Zacks reports. XWELL had a negative net margin of 81.43% and a negative return on equity of 2,318.99%.

XWELL Stock Down 3.0%

XWEL traded down $0.03 during trading hours on Friday, hitting $0.98. The stock had a trading volume of 10,722 shares, compared to its average volume of 3,547,599. The company’s fifty day simple moving average is $1.08 and its 200 day simple moving average is $1.08. XWELL has a 1 year low of $0.26 and a 1 year high of $2.20. The stock has a market cap of $8.27 million, a PE ratio of -0.17 and a beta of 1.03.

Analyst Ratings Changes

XWEL has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of XWELL in a report on Friday, August 7th. Wall Street Zen lowered XWELL from a “hold” rating to a “sell” rating in a research report on Sunday, May 17th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, XWELL presently has a consensus rating of “Sell”.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.